Navigation Links
Poor Sense of Smell May Be Early Sign of Parkinson's

Those with lowest odor identification scores had 5 times greater risk, study finds

FRIDAY, March 28 (HealthDay News) -- An impaired sense of smell could be an early indicator of Parkinson's disease, occurring up to four years before motor skill problems appear, recent research shows.

The study, published in the February issue of the Annals of Neurology, followed 2,267 men who received olfactory testing at the Kuakini Medical Center in Honolulu at least once during two periods in the 1990s. They were followed for up to eight years and, during that time, 35 of the men developed the disease.

An odor identification problem preceded the development of Parkinson's by at least four years in these men. Decreased odor identification was associated with older age, smoking, more coffee consumption, less frequent bowel movements, lower cognitive function and excessive daytime sleepiness, but even after adjusting for these factors, those with the lowest odor identification scores had a five times greater risk of developing Parkinson's than those with the highest scores.

The results strengthen findings from earlier studies that suggest olfactory impairment begins between two and seven years before diagnosis.

Why problems with smelling accompany Parkinson's is not completely understood; however, nerve loss and the formation of Lewy bodies -- abnormal clumps of proteins inside nerve cells that are thought to be a marker of the disease -- are known to take place in the olfactory structures of patients with the disease.

The study authors noted that one previous study involving brain dissection of deceased patients with neurological disease found that olfactory structures are the earliest brain regions affected by Lewy degeneration, which supports the idea that an impaired sense of smell could be one of the earliest signs of Parkinson's disease.

An impaired sense of smell could also be caused by impaired sniffing, which may be another motor symptom of Parkinson's.

Olfactory testing, along with screening for other potential early indicators of Parkinson's disease such as constipation or sleep disturbances, could provide a simple and relatively economic means of identifying individuals at high risk who could participate in trials of medications designed to prevent or slow disease progression, the authors concluded in a prepared statement.

More information

The National Institute of Neurological Disorders and Stroke has more about Parkinson's disease.

-- Kevin McKeever

SOURCE: American Neurological Association, news release, March 20, 2008

Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Antisense therapeutics scientist out to pull more big deals
2. Impaired sense of smell may be early indicator of Parkinsons disease
3. New Scenic Relaxation Videos Help Reduce Stress, Promote Sense of Calm and Tranquility
4. Sense of personal control influences Latinas decisions about sexual debut
5. URAC Names Sensei for Weight Loss as a Finalist in First-Ever Best Practices in Consumer Empowerment and Protection Awards
6. Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases
7. How do we make sense of what we see?
8. Bayer Awards Making Science Make Sense Grant to Girl Scouts
9. Redsense Medical Receives FDA Approval for Blood Loss Detection Device
10. Ex-Head of Menarini Diabetes Unit Launches WaveSense Europe
11. Majority of House of Representatives Support Common-Sense Fix to Medicare Part D Prescription Drug Plan
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... ... for mental health and wellness consultation, has collaborated with Women’s Web – ... their reader’s queries on topics on mental and emotional well-being relationship, life ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... where preparing the perfect dish and pleasing the palates of attendees is of ... bringing a dish to a seasonal get-together, give these recipes a try this ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director ... about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for ... and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
(Date:11/25/2015)... ... November 25, 2015 , ... According to an article published November ... more widely heralded as a breakthrough for performing hernia repairs. The article explains that ... surgery is that it can greatly reduce the pain that a patient might otherwise ...
(Date:11/25/2015)... Raton, Florida (PRWEB) , ... November 25, 2015 ... ... diagnostic testing for physicians and athletic programs, launches new Wimbledon Athletics ... importance of testing young athletes for unsuspected cardiac abnormalities. About 2,000 people under ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: ... License Application (BLA) with the United States ... ABP 501, a biosimilar candidate to Humira ® ... biosimilar application submitted to the FDA and represents Amgen,s ... Sean E. Harper , M.D., executive vice president ...
(Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, ... optimizing treatment outcomes for patients suffering from chronic pain, ... for a Temporary Restraining Order (TRO) enjoining Express Scripts ... two companies. --> --> ... all of its legal options. --> ...
(Date:11/25/2015)... 25, 2015 On Tuesday, November 24, ... trial against Wright Medical Technology, Inc. for product ... metal-on-metal hip implant device, awarded $11 million in ... week trial and three days of deliberations, the ... was defectively designed and unreasonably dangerous, and that ...
Breaking Medicine Technology: